Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation.
作者信息
Zafrani Lara, Dekimpe Charlotte, Joly Bérangère S, Roose Elien, Fieux Fabienne, Azoulay Elie, Peraldi Marie-Noëlle, Durrbach Antoine, Coppo Paul, Vanhoorelbeke Karen, Veyradier Agnès
机构信息
Service de Réanimation Médicale, Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, (AP-HP), Université Paris Diderot, Paris, France.
French Reference Center for Thrombotic Microangiopathies, Hôpital Saint Antoine, AP-HP, Paris, France.
出版信息
Haematologica. 2019 Jun;104(6):e277-e280. doi: 10.3324/haematol.2019.219063. Epub 2019 Feb 28.
Abstract
摘要
相似文献
1
Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation.通过肾移植转移ADAMTS13抗体介导的血栓性血小板减少性紫癜
Haematologica. 2019 Jun;104(6):e277-e280. doi: 10.3324/haematol.2019.219063. Epub 2019 Feb 28.
2
Familial acquired thrombotic thrombocytopenic purpura in siblings - no immunogenetic link with associated human leucocyte antigens.兄弟姐妹中的家族性获得性血栓性血小板减少性紫癜——与相关人类白细胞抗原无免疫遗传学联系。
Eur J Haematol. 2017 Mar;98(3):311-313. doi: 10.1111/ejh.12831. Epub 2016 Dec 7.
3
Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.血浆 ADAMTS13 生物标志物的纵向评估可预测免疫性血栓性血小板减少性紫癜的复发。
Blood Adv. 2019 Dec 23;3(24):4177-4186. doi: 10.1182/bloodadvances.2019000939.
4
Thrombotic thrombocytopenic purpura: The role of ADAMTS13.血栓性血小板减少性紫癜：ADAMTS13 的作用。
Cleve Clin J Med. 2016 Aug;83(8):597-603. doi: 10.3949/ccjm.83a.15009.
5
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.免疫介导的血栓性血小板减少性紫癜中ADAMTS13间隔区的免疫原性热点
J Thromb Haemost. 2021 Feb;19(2):478-488. doi: 10.1111/jth.15170. Epub 2020 Dec 31.
6
[Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].[血栓性血小板减少性紫癜——ADAMTS13活性的病理生理学及检测]
Rinsho Byori. 2015 Oct;63(10):1228-36.
7
ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies.ADAMTS13 检测更新：关注疑难性血栓性血小板减少性紫癜诊断的实验室方面和新疗法的效果。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:103-108. doi: 10.1111/ijlh.13557.
8
Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.获得性血栓性血小板减少性紫癜患者缓解期ADAMTS13活性的临床意义。
Blood. 2016 Oct 27;128(17):2175-2178. doi: 10.1182/blood-2016-06-724161. Epub 2016 Sep 13.
9
Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.给予化脓性链球菌免疫球蛋白G降解酶（IdeS）用于临床缓解期血栓性血小板减少性紫癜患者中持续存在的抗ADAMTS13抗体。
Br J Haematol. 2019 Jul;186(1):137-140. doi: 10.1111/bjh.15706. Epub 2018 Nov 29.
10
Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay.具有新型快速全自动 CLiA 检测法的抑制性抗 ADAMTS13 抗体。
Int J Lab Hematol. 2021 Apr;43(2):298-304. doi: 10.1111/ijlh.13372. Epub 2020 Oct 23.
引用本文的文献
1
GC1126A, a novel ADAMTS13 mutein, evades autoantibodies in immune-mediated thrombotic thrombocytopenic purpura.GC1126A，一种新型的ADAMTS13突变体，可在免疫介导的血栓性血小板减少性紫癜中逃避自身抗体。
Sci Rep. 2025 Jan 10;15(1):1613. doi: 10.1038/s41598-024-80674-x.
2
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.镰状细胞病稳态及急性血管闭塞性危机中ADAMTS13和血管性血友病因子评估
Res Pract Thromb Haemost. 2020 Dec 18;5(1):197-203. doi: 10.1002/rth2.12460. eCollection 2021 Jan.
本文引用的文献
1
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.预防性利妥昔单抗可预防免疫介导性血栓性血小板减少性紫癜的长期复发。
Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.
2
An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.ADAMTS-13 的开放构象是急性获得性血栓性血小板减少性紫癜的一个标志。
J Thromb Haemost. 2018 Feb;16(2):378-388. doi: 10.1111/jth.13922. Epub 2018 Jan 23.
3
De novo thrombotic microangiopathy after kidney transplantation.肾移植后新发血栓性微血管病。
Transplant Rev (Orlando). 2018 Jan;32(1):58-68. doi: 10.1016/j.trre.2017.10.001. Epub 2017 Nov 4.
4
Pathophysiology of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的病理生理学
Blood. 2017 Sep 7;130(10):1181-1188. doi: 10.1182/blood-2017-04-636431. Epub 2017 Aug 2.
5
Acquired thrombotic thrombocytopenic purpura in pregnancy: The role of placental and breast-milk mediated transfer of ADAMTS13-autoantibodies.
Thromb Res. 2017 Aug;156:80-81. doi: 10.1016/j.thromres.2017.06.005. Epub 2017 Jun 8.
6
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.血栓性血小板减少性紫癜及相关血栓性微血管病术语标准化的共识。
J Thromb Haemost. 2017 Feb;15(2):312-322. doi: 10.1111/jth.13571. Epub 2017 Jan 30.
7
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.伴有严重ADAMTS13缺乏的成人期血栓性微血管病（血栓性血小板减少性紫癜）的流行病学和病理生理学：法国全国血栓性微血管病登记处的横断面分析
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
8
Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13.连接区以及金属蛋白酶结构域周围的灵活性是ADAMTS-13构象激活的原因。
J Thromb Haemost. 2015 Nov;13(11):2063-75. doi: 10.1111/jth.13149. Epub 2015 Oct 20.
9
ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中的ADAMTS13和血管性血友病因子
Annu Rev Med. 2015;66:211-25. doi: 10.1146/annurev-med-061813-013241.
10
Animal models for thrombotic thrombocytopenic purpura.用于血栓性血小板减少性紫癜的动物模型。
J Thromb Haemost. 2013 Jun;11 Suppl 1:2-10. doi: 10.1111/jth.12255.
Zotero 插件